CTA Announces New Digital Health Conference Track at CES 2018
The conference will unveil the forthcoming findings of a CTA and PCHAlliance digital therapeutics research report, presented by CTA’s senior manager of market research, Lesley Rohrbaugh and Patty Mechael, executive director of the PCHAlliance. Digital therapeutics, commonly defined as technology that can improve a person’s health equal to a drug, but without the same costs and side-effects, can empower individuals to change their behavior and improve their health.